Welcome to our dedicated page for DANAHER /DE/ SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DANAHER /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DANAHER /DE/'s regulatory disclosures and financial reporting.
DANAHER CORP (DHR) director and President & CEO Blair Rainer reported indirect sales of 58,255 shares of Common Stock on 2026-08-21 through a trust. The shares were sold in multiple open-market transactions at weighted average prices between $217.21 and $219.945 per share. After these transactions, Rainer reported 37,988 shares of Common Stock held directly.
Danaher Corporation (DHR) received a notice that Rainer M. Blair plans to sell 58,255 shares of Danaher common stock under Rule 144, with Goldman Sachs & Co. LLC acting as broker. The filing lists an approximate sale date of 08/21/2026 and states that Danaher common stock is listed on the NYSE. The shares derive from multiple awards of restricted stock units granted as compensation between 2020 and 2025, all acquired from the issuer as part of compensation arrangements. The notice also reports 702,986,054 Danaher common shares outstanding and an aggregate market value of the planned sale of $12,749,106.75.
Riley Christopher Paul reported acquisition or exercise transactions in this Form 4 filing.
Danaher Corporation granted Executive Vice President Christopher Paul Riley 41,072 restricted stock units (RSUs) payable solely in common stock under its Long-Term Growth Program. The RSU award vests 50% on the 18-month and 50% on the 30-month anniversaries of the August 4, 2026 grant date, bringing his reported direct holdings to 61,472 common shares.
Danaher Corporation granted EVP & Chief Financial Officer Matthew E. Gugino an award of 153,563 employee stock options on August 4, 2026 under its Long-Term Growth Program. The options have an exercise price of $194.78 per share and are exercisable for an equal number of shares of common stock.
Fifty percent of the options become exercisable on each of the fourth and fifth anniversaries of the August 4, 2026 grant date, and they expire on August 4, 2036. Following this grant, Gugino directly holds 153,563 stock options; this transaction reflects a compensation-related award rather than an open-market purchase or sale.
Gutierrez-Ramos Jose-Carlos reported acquisition or exercise transactions in this Form 4 filing.
Danaher Corporation granted 13,477 restricted stock units payable solely in common stock to SVP and Chief Science Officer Jose-Carlos Gutierrez-Ramos on August 4, 2026, at a grant price of $0 per share.
All RSUs vest on August 4, 2026, and his direct holdings total 32,495 common shares.
Milosevich Gregory M reported acquisition or exercise transactions in this Form 4 filing.
Danaher Corporation granted 15,402 restricted stock units payable in common stock to Executive Vice President Gregory M. Milosevich on August 4, 2026, under its Long-Term Growth Plan. The RSUs vest 100% on the 24-month anniversary of the grant date. Following this award, he directly holds 24,467 shares of common stock.
Danaher Corporation granted SVP-Chief Legal Officer Jonathan Leiken employee stock options covering 92,138 shares of Common Stock at an exercise price of $194.78 per share. These options expire on August 4, 2036. According to the grant terms, fifty percent of the options become exercisable on each of the fourth and fifth anniversaries of the August 4, 2026 grant date. Following this award, Leiken directly holds derivative securities representing 92,138 underlying shares.
Danaher Corporation reported that Executive Vice President Julie A. Sawyer Montgomery received a grant of 245,701 employee stock options with an exercise price of $194.78 per share under its Long-Term Growth Program. The options vest 50% on each of the fourth and fifth anniversaries of the August 4, 2026 grant date and expire on August 4, 2036.
Danaher Corporation granted VP and Chief Accounting Officer Christopher Bouda 12,286 employee stock options on August 4, 2026. Each option permits the purchase of one share of common stock at a $194.78 exercise price and expires on August 4, 2036. Fifty percent of the options become exercisable on each of the fourth and fifth anniversaries of the August 4, 2026 grant date, and Bouda holds all 12,286 options directly following this award.
Danaher Corp director and Chairman of the Executive Committee Mitchell P. Rales received 1,000,000 non-qualified stock options on 2026-08-04 at a $194.7800 exercise price, expiring 2036-08-04, and 500,000 restricted stock units, both vesting 50% on the fourth and fifth anniversaries subject to continued employment. Following the awards he holds 553,228 common shares directly and reports indirect ownership, including 26,171,000 shares through single-member LLCs and 778,352 shares via a family trust, while disclaiming beneficial ownership of custodial shares for his daughter.